Literature DB >> 7516416

Antibodies inhibit the protease-mediated processing of a malaria merozoite surface protein.

M J Blackman1, T J Scott-Finnigan, S Shai, A A Holder.   

Abstract

When merozoites of the malaria parasite Plasmodium falciparum are released from infected erythrocytes and invade new red cells, a component of a protein complex derived from the merozoite surface protein 1 (MSP-1) precursor undergoes a single proteolytic cleavage known as secondary processing. This releases the complex from the parasite surface, except for a small membrane-bound fragment consisting of two epidermal growth factor (EGF)-like domains, which is the only part of MSP-1 to be carried into invaded erythrocytes. We report that, a group of monoclonal antibodies specific for epitopes within the EGF-like domains, some interfere with secondary processing whereas others do not. Those that most effectively inhibit processing have previously been shown to prevent invasion. Other antibodies, some of which can block this inhibition, not only do not prevent invasion but are carried into the host cell bound to the merozoite surface. These observations unequivocally demonstrate that the binding of antibody to the COOH-terminal region of MSP-1 on the merozoite surface may not be sufficient to prevent erythrocyte invasion, and show that the interaction of different antibodies with adjacent epitopes within the EGF-like domains of MSP-1 can have distinct biochemical effects on the molecule. Inhibition of MSP-1 processing on merozoites may be a mechanism by which protective antibodies interrupt the asexual cycle of the malaria parasite.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7516416      PMCID: PMC2191569          DOI: 10.1084/jem.180.1.389

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  22 in total

1.  Topography of epitopes on a polymorphic schizont antigen of Plasmodium falciparum determined by the binding of monoclonal antibodies in a two-site radioimmunoassay.

Authors:  C F Wilson; R Anand; J T Clark; J S McBride
Journal:  Parasite Immunol       Date:  1987-11       Impact factor: 2.280

2.  Serum from Pf195 protected Aotus monkeys inhibit Plasmodium falciparum growth in vitro.

Authors:  G S Hui; W A Siddiqui
Journal:  Exp Parasitol       Date:  1987-12       Impact factor: 2.011

3.  Falciparum malaria parasites invade erythrocytes that lack glycophorin A and B (MkMk). Strain differences indicate receptor heterogeneity and two pathways for invasion.

Authors:  T J Hadley; F W Klotz; G Pasvol; J D Haynes; M H McGinniss; Y Okubo; L H Miller
Journal:  J Clin Invest       Date:  1987-10       Impact factor: 14.808

4.  Characterization with monoclonal antibodies of a surface antigen of Plasmodium falciparum merozoites.

Authors:  P J Pirson; M E Perkins
Journal:  J Immunol       Date:  1985-03       Impact factor: 5.422

5.  Plasmodium falciparum: isolation and purification of spontaneously released merozoites by nylon membrane sieves.

Authors:  J E Mrema; S G Langreth; R C Jost; K H Rieckmann; H G Heidrich
Journal:  Exp Parasitol       Date:  1982-12       Impact factor: 2.011

6.  Monoclonal antibodies against a specific surface determinant on malarial (Plasmodium knowlesi) merozoites block erythrocyte invasion.

Authors:  N Epstein; L H Miller; D C Kaushel; I J Udeinya; J Rener; R J Howard; R Asofsky; M Aikawa; R L Hess
Journal:  J Immunol       Date:  1981-07       Impact factor: 5.422

7.  Passive immunization against murine malaria with an IgG3 monoclonal antibody.

Authors:  W R Majarian; T M Daly; W P Weidanz; C A Long
Journal:  J Immunol       Date:  1984-06       Impact factor: 5.422

8.  Monoclonal antibodies that protect in vivo against Plasmodium chabaudi recognize a 250,000-dalton parasite polypeptide.

Authors:  D B Boyle; C I Newbold; C C Smith; K N Brown
Journal:  Infect Immun       Date:  1982-10       Impact factor: 3.441

9.  Primary structure of the precursor to the three major surface antigens of Plasmodium falciparum merozoites.

Authors:  A A Holder; M J Lockyer; K G Odink; J S Sandhu; V Riveros-Moreno; S C Nicholls; Y Hillman; L S Davey; M L Tizard; R T Schwarz
Journal:  Nature       Date:  1985 Sep 19-25       Impact factor: 49.962

10.  Expression of the 19-kilodalton carboxy-terminal fragment of the Plasmodium falciparum merozoite surface protein-1 in Escherichia coli as a correctly folded protein.

Authors:  P A Burghaus; A A Holder
Journal:  Mol Biochem Parasitol       Date:  1994-03       Impact factor: 1.759

View more
  102 in total

1.  Immunoglobulin G3 antibodies specific for the 19-kilodalton carboxyl-terminal fragment of Plasmodium yoelii merozoite surface protein 1 transfer protection to mice deficient in Fc-gammaRI receptors.

Authors:  P Vukovic; P M Hogarth; N Barnes; D C Kaslow; M F Good
Journal:  Infect Immun       Date:  2000-05       Impact factor: 3.441

2.  Structural and antigenic properties of merozoite surface protein 4 of Plasmodium falciparum.

Authors:  L Wang; C G Black; V M Marshall; R L Coppel
Journal:  Infect Immun       Date:  1999-05       Impact factor: 3.441

3.  Small variant STEVOR antigen is uniquely located within Maurer's clefts in Plasmodium falciparum-infected red blood cells.

Authors:  M Kaviratne; S M Khan; W Jarra; P R Preiser
Journal:  Eukaryot Cell       Date:  2002-12

4.  Levels of antibody to conserved parts of Plasmodium falciparum merozoite surface protein 1 in Ghanaian children are not associated with protection from clinical malaria.

Authors:  D Dodoo; T G Theander; J A Kurtzhals; K Koram; E Riley; B D Akanmori; F K Nkrumah; L Hviid
Journal:  Infect Immun       Date:  1999-05       Impact factor: 3.441

5.  Influence of adjuvants on protection induced by a recombinant fusion protein against malarial infection.

Authors:  T M Daly; C A Long
Journal:  Infect Immun       Date:  1996-07       Impact factor: 3.441

6.  Plasmodium falciparum 19-kilodalton merozoite surface protein 1 (MSP1)-specific antibodies that interfere with parasite growth in vitro can inhibit MSP1 processing, merozoite invasion, and intracellular parasite development.

Authors:  David K Moss; Edmond J Remarque; Bart W Faber; David R Cavanagh; David E Arnot; Alan W Thomas; Anthony A Holder
Journal:  Infect Immun       Date:  2011-12-27       Impact factor: 3.441

7.  Systematic genetic analysis of the Plasmodium falciparum MSP7-like family reveals differences in protein expression, location, and importance in asexual growth of the blood-stage parasite.

Authors:  Madhusudan Kadekoppala; Solabomi A Ogun; Steven Howell; Ruwani S Gunaratne; Anthony A Holder
Journal:  Eukaryot Cell       Date:  2010-05-14

8.  Poly(I:C) adjuvant strongly enhances parasite-inhibitory antibodies and Th1 response against Plasmodium falciparum merozoite surface protein-1 (42-kDa fragment) in BALB/c mice.

Authors:  Akram Abouie Mehrizi; Niloufar Rezvani; Sedigheh Zakeri; Atefeh Gholami; Laleh Babaeekhou
Journal:  Med Microbiol Immunol       Date:  2018-02-03       Impact factor: 3.402

9.  Cryptosporidium parvum glycoprotein gp40 localizes to the sporozoite surface by association with gp15.

Authors:  Roberta M O'Connor; Jane W Wanyiri; Ana Maria Cevallos; Jeffrey W Priest; Honorine D Ward
Journal:  Mol Biochem Parasitol       Date:  2007-07-21       Impact factor: 1.759

10.  Sequential processing of merozoite surface proteins during and after erythrocyte invasion by Plasmodium falciparum.

Authors:  Michelle J Boyle; Christine Langer; Jo-Anne Chan; Anthony N Hodder; Ross L Coppel; Robin F Anders; James G Beeson
Journal:  Infect Immun       Date:  2013-11-11       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.